Synlogic Inc (SYBX)
1.78
0.00 (0.00%)
USD |
NASDAQ |
Mar 27, 16:00
1.76
-0.02
(-1.12%)
After-Hours: 20:00
Synlogic Cash from Financing (TTM): 20.94M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 20.94M |
September 30, 2023 | -0.865M |
June 30, 2023 | -0.876M |
March 31, 2023 | -1.259M |
December 31, 2022 | -2.04M |
September 30, 2022 | 0.069M |
June 30, 2022 | 48.87M |
March 31, 2022 | 81.50M |
December 31, 2021 | 89.38M |
September 30, 2021 | 97.97M |
June 30, 2021 | 50.32M |
March 31, 2021 | 21.48M |
December 31, 2020 | 13.39M |
September 30, 2020 | 4.854M |
June 30, 2020 | 3.596M |
March 31, 2020 | 79.60M |
December 31, 2019 | 79.60M |
Date | Value |
---|---|
September 30, 2019 | 79.72M |
June 30, 2019 | 79.76M |
March 31, 2019 | 28.77M |
December 31, 2018 | 82.48M |
September 30, 2018 | 82.21M |
June 30, 2018 | 149.10M |
March 31, 2018 | 120.30M |
December 31, 2017 | 66.68M |
September 30, 2017 | 66.91M |
June 30, 2017 | 0.032M |
March 31, 2017 | 0.041M |
December 31, 2016 | 0.016M |
September 30, 2016 | 60.70M |
June 30, 2016 | 60.27M |
March 31, 2016 | 66.41M |
December 31, 2015 | 101.78M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.04M
Minimum
Dec 2022
97.97M
Maximum
Sep 2021
38.74M
Average
25.13M
Median
Cash from Financing (TTM) Benchmarks
BioXcel Therapeutics Inc | 26.52M |
Inotiv Inc | -5.433M |
IGM Biosciences Inc | 115.07M |
Humacyte Inc | 4.63M |
Moderna Inc | -1.377B |